K.Vita addresses an unmet need for those who cannot access KD services.Further study is warranted; however, in particular, for individuals for whom observance of aKD may prove too challenging and outweigh any clinical benefits, and for specific disordersdependent on a KD, such as GLUT1-DS, and conditions with paroxysmal neurological events,such as AHC, with use of K.Vita alongside minimal dietary modification compared to atraditional KD, as in this study. This evidence concerns the gene SLC2A1 and alternating hemiplegia of childhood.